| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/28/2002 | WO2001070977A3 Fibroblast growth factor receptor-like molecules and uses thereof |
| 03/28/2002 | WO2001068839A3 Regulation of human lipoxin a4 receptor-like protein |
| 03/28/2002 | WO2001066596A3 Human fgf-23 gene and gene expression products |
| 03/28/2002 | WO2001066144A3 Antineoplastic combination comprising an inhibitor of angiogenesis and an inhibitor of dna topoisomerase i enzyme activity |
| 03/28/2002 | WO2001064736A3 Proliferation arrest transcription factor and its use |
| 03/28/2002 | WO2001064714A3 Compounds and methods for modulating cell-adhesion mediated drug resistance |
| 03/28/2002 | WO2001062791A3 Control of tgf (beta) signaling by km23 superfamily members |
| 03/28/2002 | WO2001062272A3 Soluble tumor necrosis factor receptor and il-4 inhibitor for the treatment of medical disorders |
| 03/28/2002 | WO2001060973A3 C/ebpbeta isoforms and methods of use in cell regulation and anti-tumorigenesis |
| 03/28/2002 | WO2001060864A3 Human ion channels |
| 03/28/2002 | WO2001058476A3 Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity |
| 03/28/2002 | WO2001057194A3 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 03/28/2002 | WO2001057182A3 Nucleic acids, proteins, and antibodies |
| 03/28/2002 | WO2001055357A3 Myeloid colony stimulating factor and uses thereof |
| 03/28/2002 | WO2001055356A3 Human protein kinases and protein kinase-like enzymes |
| 03/28/2002 | WO2001051642A3 Dna modification proteins |
| 03/28/2002 | WO2001051032A3 Micronized freeze-dried particles |
| 03/28/2002 | WO2001049729A3 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use |
| 03/28/2002 | WO2001046227A3 'dispatched' polypeptides |
| 03/28/2002 | WO2001044177A3 Somatostatin analogs, radiolabelled derivatives thereof and their use |
| 03/28/2002 | WO2001039758A3 Method for the treatment and/or prophylaxis of diseases caused by il-12 using thalidomide and anti-inflammatory cytokine |
| 03/28/2002 | WO2001038552A3 Excipient system that contains coating substances with enzymatically removable side-groups |
| 03/28/2002 | WO2001038486A3 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | WO2001032885A3 Human lipase |
| 03/28/2002 | WO2001025267A3 Improved ricin-like toxins for treatment of cancer |
| 03/28/2002 | WO2001019353A3 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth |
| 03/28/2002 | WO2001009183A3 Polymorphisms in the human mdr-1 gene and applications thereof |
| 03/28/2002 | WO2001007405A3 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 03/28/2002 | WO2000063241A9 Methods and compositions for modulating an immune response |
| 03/28/2002 | WO2000060051A3 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 03/28/2002 | WO2000056327A9 Ascorbic acid composition and method for treatment of aging or damaged skin |
| 03/28/2002 | WO2000048621A9 Methods and compositions for regulating protein-protein interactions |
| 03/28/2002 | WO2000047231A9 Novel antisense inhibition of rad51 |
| 03/28/2002 | US20020038469 Delayed progression to aids by a missense allele of the ccr2 gene |
| 03/28/2002 | US20020038150 Injectable implants for tissue augmentation and restoration |
| 03/28/2002 | US20020038017 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 03/28/2002 | US20020038012 Can be used for diagnosis, drug screening, clinical trial monitoring and the treatment of physiological disorders |
| 03/28/2002 | US20020038009 Novel human kinase protein and polynucleotides encoding the same |
| 03/28/2002 | US20020038007 Method of finding agonist and antagonist to human 11cb splice variant |
| 03/28/2002 | US20020038003 Novel antibody recognizing a small subset of human hematopoietic cells |
| 03/28/2002 | US20020037998 For therapy of hepatitis C virus (HCV) infection |
| 03/28/2002 | US20020037908 For solubilizing a conformationally altered protein, comprising a carboxylic acid anion of picolinic acid, its analogs, or derivatives thereof and a cation; treating Alzheimer's disease or Creutzfelds-Jakob disease for example |
| 03/28/2002 | US20020037890 Synergistic; treating grampositive and gramnegative bacterial infections, kits |
| 03/28/2002 | US20020037889 Imidazolidin-2-one derivatives; inhibiting bone resorption, vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation, arthritis, viral disease, cancer and metastatic tumor growth |
| 03/28/2002 | US20020037879 Monoclonal antibodies; veterinary medicine |
| 03/28/2002 | US20020037869 Human bad polypeptides, encoding nucleic acids and methods of use |
| 03/28/2002 | US20020037860 Method for reducing or preventing the establishment, growth or metastasis of cancer by administering indazole peptidomimetics PAR-1 antagonist and optionally PAR-2 antagonists |
| 03/28/2002 | US20020037859 Antiarthritic agents; antiinflammatory agents |
| 03/28/2002 | US20020037857 Therapy for blood disorders |
| 03/28/2002 | US20020037855 Stabilized medicament containing cysteinyl derivatives |
| 03/28/2002 | US20020037854 Use of at least one no synthase inhibitor for treating sensitive skin |
| 03/28/2002 | US20020037853 Polypeptides |
| 03/28/2002 | US20020037852 Anticarcinogenic agents |
| 03/28/2002 | US20020037851 Codes with nucleic acids; antiinflammatory agents |
| 03/28/2002 | US20020037850 Genetic engineering; binding to antibodies |
| 03/28/2002 | US20020037849 Anticholesterol agents; hypotensive agents; polypeptide |
| 03/28/2002 | US20020037848 Alzheimer's disease; Parkinson's disease |
| 03/28/2002 | US20020037847 Nucleic acids encoding kringle 1-5 region fragments of plasminogen |
| 03/28/2002 | US20020037846 Use of calcitonin gene-related peptide in the prevention and alleviation of asthma and related bronchospastic pulmonary diseases |
| 03/28/2002 | US20020037845 Polypeptide with appetite regulating activity |
| 03/28/2002 | US20020037844 Synthetic peptide for treatment of autoimmune arthritis |
| 03/28/2002 | US20020037843 Method and composition for modulating amyloidosis |
| 03/28/2002 | US20020037842 Mucin containing ophthalmic preparation |
| 03/28/2002 | US20020037841 Blood disorders; drug in aqueous solution |
| 03/28/2002 | US20020037840 Fusion protein |
| 03/28/2002 | US20020037839 Antiischemic agents; hypotensive agents; antiiflammatory agents |
| 03/28/2002 | US20020037836 Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders |
| 03/28/2002 | US20020037835 Antitumor agents |
| 03/28/2002 | US20020037833 Administering botulinium toxin component coupled to substance P |
| 03/28/2002 | US20020037832 Use of alpha-MSH and EPO for preventing or treating ischemic conditions |
| 03/28/2002 | US20020037831 1-Nitroacridine/tumor inhibitor compositions |
| 03/28/2002 | US20020037830 Adjust glycogen concentration |
| 03/28/2002 | US20020037827 Genetic engineering |
| 03/28/2002 | US20020037585 Detecting modulator of preferential gene expression; obtain cell from human or nematode, incubate cells with modulator, monitor cells for decrease in preferential gene expresssion |
| 03/28/2002 | US20020037584 Use of nerve growth factor for the storage, culture or treatment of cornea |
| 03/28/2002 | US20020037583 Transforming cells with preferfential nucleotide sequences; obtain cells, transform, with vector, express vector, recover preferential proteins |
| 03/28/2002 | US20020037575 Recombinant virus vectors |
| 03/28/2002 | US20020037574 Recombinant C-proteinase and processes, methods and uses thereof |
| 03/28/2002 | US20020037572 Novel mammalian secreted group III phospholipase A2 |
| 03/28/2002 | US20020037567 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of collagen defects |
| 03/28/2002 | US20020037566 Apparatus for use in treating in injuries; wound healing agent |
| 03/28/2002 | US20020037557 Nucleotide sequences which code proteins for use in the treatment of nervous system, cardiovascular and liver disorders; for use in treatment of burns, traumatic injuries, surgery and ulcers |
| 03/28/2002 | US20020037555 Human glucose-6-phosphatase molecules and uses thereof |
| 03/28/2002 | US20020037553 Fragments of leptin (ob protein) |
| 03/28/2002 | US20020037551 Polypeptide; for use in diagnosis and treatment of infections, anemia, nephritis, respiratory and cardiovascular disorders |
| 03/28/2002 | US20020037549 ABC transport polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | US20020037543 Purging of cells using viruses |
| 03/28/2002 | US20020037541 Isolated nucleic acid molecules associated with gastric cancer and methods for diagnosing and treating gastric cancer |
| 03/28/2002 | US20020037538 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis |
| 03/28/2002 | US20020037535 Contacting the cells (other than cancer cells and megakaryocyte progenitor cells) with a modified C-reactive protein or a mutant or mutant, modified C-reactive protein; in vitro or in vivo; |
| 03/28/2002 | US20020037524 Nucleotide sequences for use in diagnosis, treatment and prevention of cancer, inflammation, autoimmune disease and infections |
| 03/28/2002 | US20020037523 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of nervous system, autoimmune, inflammation, glomerulonephritis and osteoporosis disorders |
| 03/28/2002 | US20020037522 Protein; for use in the prevention of antibiotic resistance in cancer therapy |
| 03/28/2002 | US20020037518 Polypeptide for use in the diagnosis, prevention and treatment of cell proliferation and inflammation defects |
| 03/28/2002 | US20020037503 Reagents and methods useful for detecting diseases of the breast |
| 03/28/2002 | US20020037497 Suppressing viral activity in virally infected cells; obtain cells, incubate with viricide, monitoring cell inhibition enzyme activity |
| 03/28/2002 | US20020037357 Hypoallergenic composition containing tolerogenic peptides |
| 03/28/2002 | US20020037326 Peptides for inhibiting retroviruses |
| 03/28/2002 | US20020037316 Phospholipid-based powders for drug delivery |
| 03/28/2002 | US20020037314 For therapy of rosacea or other inflammatory skin affliction, cosmetics |